2020
Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Faridi KF, Tamez H, Strom JB, Song Y, Butala NM, Shen C, Secemsky EA, Mauri L, Curtis JP, Gibson CM, Yeh RW. Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. Circulation 2020, 142: 306-308. PMID: 32687440, PMCID: PMC7374757, DOI: 10.1161/circulationaha.120.047729.Peer-Reviewed Original ResearchConceptsDual antiplatelet therapyPercutaneous coronary interventionAdministrative claims dataAntiplatelet therapyCoronary interventionClaims dataTreatment effects
2018
The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure
Kundi H, Popma JJ, Valsdottir LR, Shen C, Faridi KF, Pinto DS, Yeh RW. The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure. Canadian Journal Of Cardiology 2018, 34: 1648-1654. PMID: 30527154, PMCID: PMC6424362, DOI: 10.1016/j.cjca.2018.10.002.Peer-Reviewed Original ResearchConceptsNontraditional risk factorsLong-term mortalityNoncardiac risk factorsMitral valve repairRisk factorsValve repairMitraClip procedureClaims dataLong-term mortality riskPercutaneous mitral valve repairTranscatheter mitral valve repairPredicting Long-Term MortalityCardiac risk factorsPresentation characteristicsCox regression modelAdministrative claims dataRisk prediction modelMedian followMitraClip implantationModel discriminationMortality riskClaims codesMedicare feePatientsService beneficiaries